SCHEMBL645070

SCHEMBL645070

CCC(C)OC(=O)CCC(=O)OC(C)CC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA3 P07451 1/20 0.45
CA4 P22748 1/20 0.45
CA6 P23280 1/20 0.45
CA5A P35218 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
CA13 Q8N1Q1 1/20 0.45
CA14 Q9ULX7 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
LMNA P02545 4/20 0.45
EPHX2 P34913 1/20 0.43
TSHR P16473 2/20 0.39
MAPT P10636 3/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 2/20 0.36
FAAH O00519 4/20 0.35
CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644570 0.91 EGLN1 (0.43) CA12CA1CA2CA3CA4
SCHEMBL19821825 0.91 TSHR (0.56) CA12CA1CA2CA3CA4
SCHEMBL2710286 0.91 ALDH1A1 (0.43) CA12CA1CA2CA3CA4
SCHEMBL1585214 0.90 ALDH1A1 (0.50) CA12CA1CA2CA3CA4
SCHEMBL2980900 0.90 ALDH1A1 (0.50) CA12CA1CA2CA3CA4
SCHEMBL10554751 0.90 LMNA (0.57) CA12CA1CA2CA3CA4
SCHEMBL2989645 0.90 ALDH1A1 (0.50) CA12CA1CA2CA3CA4
SCHEMBL6231000 0.90 LMNA (0.52) CA12CA1CA2CA3CA4
SCHEMBL27512518 0.89 CYP1A2 (0.45) CA12CA1CA2CA3CA4
SCHEMBL3504151 0.88 LMNA (0.41) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787918-B2 Biobased compositions Evoco Limited (CA) 2023-10-17 US claimed
CN-115109430-A Pigment and preparation method thereof 宁夏彩妍科技有限公司 2022-09-27 CN claimed
WO-2022174333-A1 BIOBASED COMPOSITIONS Evoco Limited (CA) 2022-08-25 WO claimed
US-20220259402-A1 BIOBASED COMPOSITIONS Evoco Limited (CA) 2022-08-18 US claimed
US-4209438-A CROSSLINKED POLYESTER IN DIFUNCTIONAL CARBOXYLIC ESTER SOLVENT HITACHI CHEMICAL COMPANY, LTD. (JP) 1980-06-24 US claimed
US-11787918-B2 Biobased compositions Evoco Limited (CA) 2023-10-17 US disclosed
CN-115109430-A Pigment and preparation method thereof 宁夏彩妍科技有限公司 2022-09-27 CN disclosed
WO-2022174333-A1 BIOBASED COMPOSITIONS Evoco Limited (CA) 2022-08-25 WO disclosed
US-20220259402-A1 BIOBASED COMPOSITIONS Evoco Limited (CA) 2022-08-18 US disclosed
EP-2723750-B1 DIKETOPYRROLOPYRROLE OLIGOMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES CLAP CO LTD (KR) 2022-08-10 EP disclosed
US-11136421-B2 Solid catalyst component for use in olefin polymerisation, catalyst, and application thereof BEIJING LIHE TECHNOLOGY LTD (CN) 2021-10-05 US disclosed
US-11072694-B1 Biobased compositions Evoco Limited (CA) 2021-07-27 US disclosed
US-4482653-A Cyclopentadiene derivatives, method for preparing, and use thereof ASHLAND OIL, INC. (US) 1984-11-13 US disclosed
US-4464521-A EPOXIDIZED FULVENES AS BINDER FOR AGGREGATE; FOUNDRY BINDERS ASHLAND OIL, INC. (US) 1984-08-07 US disclosed
US-4412088-A CURABLE BINDER COMPOSITIONS ASHLAND OIL, INC. (US) 1983-10-25 US disclosed
US-4390675-A EPOXYFULVENE, ACID CATALYST ASHLAND OIL, INC. (US) 1983-06-28 US disclosed
US-4220578-A Method, resin and catalyst for increasing the tensile strength and core hardness of a sand mold or core CL INDUSTRIES INC. (US) 1980-09-02 US disclosed
US-4215012-A SULFUR-FREE; DIALKYL ESTER COMPOUND AND A LEWIS ACID, POLYMERIZATION CATALYST C L INDUSTRIES, INC. (US) 1980-07-29 US disclosed
US-4209438-A CROSSLINKED POLYESTER IN DIFUNCTIONAL CARBOXYLIC ESTER SOLVENT HITACHI CHEMICAL COMPANY, LTD. (JP) 1980-06-24 US disclosed
US-4085274-A OXIDIZING CYCLODODECEN-1-YLPROPIONIC ACID DERIVATIVE DAICEL LTD. (JA) 1978-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11072694-B1 Biobased compositions SORD, SCD, ACMSD CA12 890/4885CA1 1115/4885CA2 3297/4885
US-20220259402-A1 BIOBASED COMPOSITIONS SORD, SCD, ACMSD CA12 890/4885CA1 1115/4885CA2 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.